649 related articles for article (PubMed ID: 31578541)
1. A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis.
Nutma E; Stephenson JA; Gorter RP; de Bruin J; Boucherie DM; Donat CK; Breur M; van der Valk P; Matthews PM; Owen DR; Amor S
Brain; 2019 Nov; 142(11):3440-3455. PubMed ID: 31578541
[TBL] [Abstract][Full Text] [Related]
2. Activated microglia do not increase 18 kDa translocator protein (TSPO) expression in the multiple sclerosis brain.
Nutma E; Gebro E; Marzin MC; van der Valk P; Matthews PM; Owen DR; Amor S
Glia; 2021 Oct; 69(10):2447-2458. PubMed ID: 34145928
[TBL] [Abstract][Full Text] [Related]
3. Translocator protein 18 kDa (TSPO) expression in multiple sclerosis patients.
Harberts E; Datta D; Chen S; Wohler JE; Oh U; Jacobson S
J Neuroimmune Pharmacol; 2013 Mar; 8(1):51-7. PubMed ID: 22956240
[TBL] [Abstract][Full Text] [Related]
4. Pro-inflammatory activation of primary microglia and macrophages increases 18 kDa translocator protein expression in rodents but not humans.
Owen DR; Narayan N; Wells L; Healy L; Smyth E; Rabiner EA; Galloway D; Williams JB; Lehr J; Mandhair H; Peferoen LA; Taylor PC; Amor S; Antel JP; Matthews PM; Moore CS
J Cereb Blood Flow Metab; 2017 Aug; 37(8):2679-2690. PubMed ID: 28530125
[TBL] [Abstract][Full Text] [Related]
5. In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand ¹¹C-PK11195.
Rissanen E; Tuisku J; Rokka J; Paavilainen T; Parkkola R; Rinne JO; Airas L
J Nucl Med; 2014 Jun; 55(6):939-44. PubMed ID: 24711650
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the 18 kDa translocator protein (TSPO) expression in post-mortem normal and Alzheimer's disease brains.
Gui Y; Marks JD; Das S; Hyman BT; Serrano-Pozo A
Brain Pathol; 2020 Jan; 30(1):151-164. PubMed ID: 31276244
[TBL] [Abstract][Full Text] [Related]
7. Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal Models.
Nack A; Brendel M; Nedelcu J; Daerr M; Nyamoya S; Beyer C; Focke C; Deussing M; Hoornaert C; Ponsaerts P; Schmitz C; Bartenstein P; Rominger A; Kipp M
Cells; 2019 Jan; 8(2):. PubMed ID: 30696113
[TBL] [Abstract][Full Text] [Related]
8. In Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with (18)F-PBR111 PET.
Colasanti A; Guo Q; Muhlert N; Giannetti P; Onega M; Newbould RD; Ciccarelli O; Rison S; Thomas C; Nicholas R; Muraro PA; Malik O; Owen DR; Piccini P; Gunn RN; Rabiner EA; Matthews PM
J Nucl Med; 2014 Jul; 55(7):1112-8. PubMed ID: 24904112
[TBL] [Abstract][Full Text] [Related]
9. Translocator protein PET imaging for glial activation in multiple sclerosis.
Oh U; Fujita M; Ikonomidou VN; Evangelou IE; Matsuura E; Harberts E; Fujimura Y; Richert ND; Ohayon J; Pike VW; Zhang Y; Zoghbi SS; Innis RB; Jacobson S
J Neuroimmune Pharmacol; 2011 Sep; 6(3):354-61. PubMed ID: 20872081
[TBL] [Abstract][Full Text] [Related]
10. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
Datta G; Colasanti A; Rabiner EA; Gunn RN; Malik O; Ciccarelli O; Nicholas R; Van Vlierberghe E; Van Hecke W; Searle G; Santos-Ribeiro A; Matthews PM
Brain; 2017 Nov; 140(11):2927-2938. PubMed ID: 29053775
[TBL] [Abstract][Full Text] [Related]
11. Endotoxin-induced systemic inflammation activates microglia: [¹¹C]PBR28 positron emission tomography in nonhuman primates.
Hannestad J; Gallezot JD; Schafbauer T; Lim K; Kloczynski T; Morris ED; Carson RE; Ding YS; Cosgrove KP
Neuroimage; 2012 Oct; 63(1):232-9. PubMed ID: 22776451
[TBL] [Abstract][Full Text] [Related]
12. Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis.
Sucksdorff M; Matilainen M; Tuisku J; Polvinen E; Vuorimaa A; Rokka J; Nylund M; Rissanen E; Airas L
Brain; 2020 Dec; 143(11):3318-3330. PubMed ID: 33006604
[TBL] [Abstract][Full Text] [Related]
13. Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [
Sridharan S; Raffel J; Nandoskar A; Record C; Brooks DJ; Owen D; Sharp D; Muraro PA; Gunn R; Nicholas R
Mol Imaging Biol; 2019 Oct; 21(5):935-944. PubMed ID: 30796709
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Effect of Fingolimod Treatment on Microglial Activation Using Serial PET Imaging in Multiple Sclerosis.
Sucksdorff M; Rissanen E; Tuisku J; Nuutinen S; Paavilainen T; Rokka J; Rinne J; Airas L
J Nucl Med; 2017 Oct; 58(10):1646-1651. PubMed ID: 28336784
[TBL] [Abstract][Full Text] [Related]
15. Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions.
Kaunzner UW; Kang Y; Zhang S; Morris E; Yao Y; Pandya S; Hurtado Rua SM; Park C; Gillen KM; Nguyen TD; Wang Y; Pitt D; Gauthier SA
Brain; 2019 Jan; 142(1):133-145. PubMed ID: 30561514
[TBL] [Abstract][Full Text] [Related]
16. In vivo imaging of microglial activation by positron emission tomography with [(11)C]PBR28 in the 5XFAD model of Alzheimer's disease.
Mirzaei N; Tang SP; Ashworth S; Coello C; Plisson C; Passchier J; Selvaraj V; Tyacke RJ; Nutt DJ; Sastre M
Glia; 2016 Jun; 64(6):993-1006. PubMed ID: 26959396
[TBL] [Abstract][Full Text] [Related]
17. An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28.
Owen DR; Yeo AJ; Gunn RN; Song K; Wadsworth G; Lewis A; Rhodes C; Pulford DJ; Bennacef I; Parker CA; StJean PL; Cardon LR; Mooser VE; Matthews PM; Rabiner EA; Rubio JP
J Cereb Blood Flow Metab; 2012 Jan; 32(1):1-5. PubMed ID: 22008728
[TBL] [Abstract][Full Text] [Related]
18. Mixed-affinity binding in humans with 18-kDa translocator protein ligands.
Owen DR; Gunn RN; Rabiner EA; Bennacef I; Fujita M; Kreisl WC; Innis RB; Pike VW; Reynolds R; Matthews PM; Parker CA
J Nucl Med; 2011 Jan; 52(1):24-32. PubMed ID: 21149489
[TBL] [Abstract][Full Text] [Related]
19. Detection of microglial activation in an acute model of neuroinflammation using PET and radiotracers 11C-(R)-PK11195 and 18F-GE-180.
Dickens AM; Vainio S; Marjamäki P; Johansson J; Lehtiniemi P; Rokka J; Rinne J; Solin O; Haaparanta-Solin M; Jones PA; Trigg W; Anthony DC; Airas L
J Nucl Med; 2014 Mar; 55(3):466-72. PubMed ID: 24516258
[TBL] [Abstract][Full Text] [Related]
20.
Datta G; Colasanti A; Kalk N; Owen D; Scott G; Rabiner EA; Gunn RN; Lingford-Hughes A; Malik O; Ciccarelli O; Nicholas R; Nei L; Battaglini M; De Stefano N; Matthews PM
J Nucl Med; 2017 Sep; 58(9):1477-1482. PubMed ID: 28302760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
